Form of presentation | Articles in international journals and collections |
Year of publication | 2022 |
|
Blatt Nataliya Lvovna, author
|
Other authors |
Abdulganieva Diana Ildarovna, Mukhametova Dilyara Damirovna, Valeeva Ildariya Khayrullovna, Zinkevich Oleg Danilovich, Safina Nellya Akhmetovna, Odincova Alfiya Kharisovna |
|
Korovina Marina Olegovna, postgraduate kfu
|
Bibliographic description in the original language |
Abdulganieva D.I., Mukhametova D.D., Valeeva I. K, Blatt N., Zinkevich?O.D., Safina N.A., Odintsova A. Kh., Korovina M.O. Faecal Neutrophil Gelatinase associated Lipocalin as a Non invasive Biomarker in Inflammatory Bowel Disease // BioNanoScience (2022). 12:1381?1387 https://doi.org/10.1007/s12668-022-00999-7 |
Annotation |
The aim was to evaluate NGAL level in faeces in patients with IBD. We included 107 patients with IBD ? 96 cases of IBD flare up (66 ? UC and 29 ? CD), 11 patients in IBD remission (6 ? UC and 6 ? CD) and 30 healthy controls. There was a confirmed faecal NGAL level in all patients. Faecal NGAL was significantly higher in active IBD ? 4122 [861; 6850] ng/ml comparing with healthy persons ? 181 [169; 720] ng/ml (p < 0,001) or inactive IBD ? 1136 [116; 3004] ng/ml (p < 0,05). In active UC (4668 [1298; 7792] ng/ml), it was higher than in active CD (2688 [200; 5710] ng/ml) (p < 0.05). We found that faecal NGAL as a marker has sensitivity of 72.9%, specificity of 93.3% and AUC of 0.88 for distinguishing IBD from healthies. Sensitivity, specificity and AUC were 72.9%, 45.5% and 0.72, respectively, for distinguishing exacerbation from remission of disease. Faecal NGAL is a new promising marker for diagnosis active IBD, which has high sensitivity, specificity and AUC. |
Keywords |
Infammatory bowel disease, Crohn?s disease, Ulcerative colitis, Lipocalin-2 ,Neutrophil gelatinase-associated lipocalin, NGAL |
The name of the journal |
BioNanoScience
|
Publishing house |
Springer |
URL |
https://link.springer.com/article/10.1007/s12668-022-00999-7 |
Please use this ID to quote from or refer to the card |
https://repository.kpfu.ru/eng/?p_id=281652&p_lang=2 |
Full metadata record |
Field DC |
Value |
Language |
dc.contributor.author |
Blatt Nataliya Lvovna |
ru_RU |
dc.contributor.author |
Korovina Marina Olegovna |
ru_RU |
dc.date.accessioned |
2022-01-01T00:00:00Z |
ru_RU |
dc.date.available |
2022-01-01T00:00:00Z |
ru_RU |
dc.date.issued |
2022 |
ru_RU |
dc.identifier.citation |
Abdulganieva D.I., Mukhametova D.D., Valeeva I. K, Blatt N., Zinkevich?O.D., Safina N.A., Odintsova A. Kh., Korovina M.O. Faecal Neutrophil Gelatinase associated Lipocalin as a Non invasive Biomarker in Inflammatory Bowel Disease // BioNanoSciencе (2022). 12:1381?1387 https://doi.org/10.1007/s12668-022-00999-7 |
ru_RU |
dc.identifier.uri |
https://repository.kpfu.ru/eng/?p_id=281652&p_lang=2 |
ru_RU |
dc.description.abstract |
BioNanoScience |
ru_RU |
dc.description.abstract |
The aim was to evaluate NGAL level in faeces in patients with IBD. We included 107 patients with IBD ? 96 cases of IBD flare up (66 ? UC and 29 ? CD), 11 patients in IBD remission (6 ? UC and 6 ? CD) and 30 healthy controls. There was a confirmed faecal NGAL level in all patients. Faecal NGAL was significantly higher in active IBD ? 4122 [861; 6850] ng/ml comparing with healthy persons ? 181 [169; 720] ng/ml (p < 0,001) or inactive IBD ? 1136 [116; 3004] ng/ml (p < 0,05). In active UC (4668 [1298; 7792] ng/ml), it was higher than in active CD (2688 [200; 5710] ng/ml) (p < 0.05). We found that faecal NGAL as a marker has sensitivity of 72.9%, specificity of 93.3% and AUC of 0.88 for distinguishing IBD from healthies. Sensitivity, specificity and AUC were 72.9%, 45.5% and 0.72, respectively, for distinguishing exacerbation from remission of disease. Faecal NGAL is a new promising marker for diagnosis active IBD, which has high sensitivity, specificity and AUC. |
ru_RU |
dc.language.iso |
ru |
ru_RU |
dc.publisher |
Springer |
ru_RU |
dc.subject |
Infammatory bowel disease |
ru_RU |
dc.subject |
Crohn?s disease |
ru_RU |
dc.subject |
Ulcerative colitis |
ru_RU |
dc.subject |
Lipocalin-2 |
ru_RU |
dc.subject |
Neutrophil gelatinase-associated lipocalin |
ru_RU |
dc.subject |
NGAL |
ru_RU |
dc.title |
Faecal Neutrophil Gelatinase associated Lipocalin as a Non invasive Biomarker in Inflammatory Bowel Disease |
ru_RU |
dc.type |
Articles in international journals and collections |
ru_RU |
|